Invitro Specialitylab Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 10-07-2024
- Paid Up Capital ₹ 1.00 Cr
as on 10-07-2024
- Company Age 7 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 26.49%
(FY 2021)
- Profit 234.51%
(FY 2021)
- Ebitda 3243.21%
(FY 2021)
- Net Worth 21.25%
(FY 2021)
- Total Assets 29.20%
(FY 2021)
About Invitro Specialitylab
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rameshchandra Shah, Naresh Laddha, Ilesh Patel, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999GJ2017PTC098050
- Company No.
098050
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jun 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Invitro Specialitylab?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ilesh Patel  | Director | 04-Jul-2017 | Current |
| Rameshchandra Shah | Director | 27-Jun-2017 | Current |
| Naresh Laddha | Director | 27-Jun-2017 | Current |
Chiragbhai Patel  | Director | 13-Jul-2018 | Current |
Financial Performance of Invitro Specialitylab.
Invitro Specialitylab Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 26.49% increase. The company also saw a substantial improvement in profitability, with a 234.51% increase in profit. The company's net worth Soared by an impressive increase of 21.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Invitro Specialitylab?
In 2021, Invitro Specialitylab had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Invitro Specialitylab?
Invitro Specialitylab has a workforce of 0 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Invitro Specialitylab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Invitro Specialitylab's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
